» Articles » PMID: 31630319

Venlafaxine Inhibits Naloxone-precipitated Morphine Withdrawal Symptoms: Role of Inflammatory Cytokines and Nitric Oxide

Overview
Journal Metab Brain Dis
Publisher Springer
Specialties Endocrinology
Neurology
Date 2019 Oct 21
PMID 31630319
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Opioid-induced neuroinflammation plays a role in the development of opioid physical dependence. Moreover, nitric oxide (NO) has been implicated in several oxidative and inflammatory pathologies. Here, we sought to determine whether treatment with venlafaxine during the development of morphine dependence could inhibit naloxone-precipitated withdrawal symptoms. The involvement of neuro-inflammation related cytokines, oxidative stress, and L-arginine (L-arg)-NO pathway in these effects were also investigated. Mice received morphine (50 mg/kg/daily; s.c.), plus venlafaxine (5 and 40 mg/kg, i.p.) once a day for 3 consecutive days. In order to evaluate the possible role of L-arg-NO on the effects caused by venlafaxine, animals received L-arg, L-NAME or aminoguanidine with venlafaxine (40 mg/kg, i.p.) 30 min before each morphine injection for 3 consecutive days. On 4 day of experiment, behavioral signs of morphine-induced physical dependence were evaluated after i.p. naloxone injection. Then, brain levels of tissue necrosis factor-alpha (TNF-α), interleukin-1-beta (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10), brain-derived neurotrophic factor (BDNF), NO and oxidative stress factors including; total thiol, malondialdehyde (MDA) contents and glutathione peroxidase (GPx) activity were determined. Co-administration of venlafaxine (40 mg/kg) with morphine not only inhibited the naloxone-precipitated withdrawal signs including jumping and weight loss, but also reduced the up-regulation of TNF-α, IL-1β, IL-6, NO and MDA contents in mice brain tissue. However, repeated administration of venlafaxine inhibited the decrease in the brain levels of BDNF, total thiol and GPx. Pre-administration of L-NAME and aminoguanidine improved, while L-arg antagonized the venlafaxine-induced effects. These results provide evidences that venlafaxine could be used as a candidate drug to inhibit morphine withdrawal through the involvement of inflammatory cytokines and l-arginine-NO in mice.

Citing Articles

Modulation of oxidative stress/NMDA/nitric oxide pathway by topiramate attenuates morphine dependence in mice.

Hussain S, Bahadar H, Khan M, Qazi N, Wazir S, Ahmad H Heliyon. 2024; 10(23):e40584.

PMID: 39719994 PMC: 11667026. DOI: 10.1016/j.heliyon.2024.e40584.


The epigenetic signatures of opioid addiction and physical dependence are prevented by D-cysteine ethyl ester and betaine.

McDonough J, Singhal N, Getsy P, Knies K, Knauss Z, Mueller D Front Pharmacol. 2024; 15:1416701.

PMID: 39281282 PMC: 11392886. DOI: 10.3389/fphar.2024.1416701.


The Effect of Neuropsychiatric Drugs on the Oxidation-Reduction Balance in Therapy.

Sommerfeld-Klatta K, Jiers W, Rzepczyk S, Nowicki F, Lukasik-Glebocka M, Swiderski P Int J Mol Sci. 2024; 25(13).

PMID: 39000411 PMC: 11242277. DOI: 10.3390/ijms25137304.


Lipophilic analogues of D-cysteine prevent and reverse physical dependence to fentanyl in male rats.

Bates J, Getsy P, Coffee G, Baby S, MacFarlane P, Hsieh Y Front Pharmacol. 2024; 14:1336440.

PMID: 38645835 PMC: 11026688. DOI: 10.3389/fphar.2023.1336440.


L-cysteine ethyl ester prevents and reverses acquired physical dependence on morphine in male Sprague Dawley rats.

Bates J, Getsy P, Coffee G, Baby S, MacFarlane P, Hsieh Y Front Pharmacol. 2023; 14:1303207.

PMID: 38111383 PMC: 10726967. DOI: 10.3389/fphar.2023.1303207.


References
1.
Zubelewicz B, Muc-Wierzgon M, Harbuz M, Brodziak A . Central single and chronic administration of morphine stimulates corticosterone and interleukin (IL)-6 in adjuvant-induced arthritis. J Physiol Pharmacol. 2001; 51(4 Pt 2):897-906. View

2.
Feng P, Meissler Jr J, Adler M, Eisenstein T . Morphine withdrawal sensitizes mice to lipopolysaccharide: elevated TNF-alpha and nitric oxide with decreased IL-12. J Neuroimmunol. 2005; 164(1-2):57-65. DOI: 10.1016/j.jneuroim.2005.03.017. View

3.
Vollmar P, Haghikia A, Dermietzel R, Faustmann P . Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model. Int J Neuropsychopharmacol. 2007; 11(1):111-7. DOI: 10.1017/S1461145707007729. View

4.
Li Z, Qi D, Chen J, Zhang C, Yi Z, Yuan C . Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study. Psychoneuroendocrinology. 2012; 38(1):107-14. DOI: 10.1016/j.psyneuen.2012.05.005. View

5.
Kumar A, Garg R, Gaur V, Kumar P . Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice. Neurosci Lett. 2009; 467(2):72-5. DOI: 10.1016/j.neulet.2009.10.004. View